权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Sex divergence and cell specificity of age-related hippocampal DNA modifications

年龄相关海马 DNA 修饰的性别差异和细胞特异性

基本信息

批准号：
10615662
负责人：
WILLARD M FREEMAN
金额：
$ 53.55万
依托单位：
OKLAHOMA MEDICAL RESEARCH FOUNDATION
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-07-01 至 2025-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10615662
关键词：
Address Age Aging Alleles Alzheimer&apos s Disease Animal Model Animals Astrocytes Biochemical Bioinformatics Biological Biological Assay Brain Caloric Restriction Cells Central Nervous System Chromatin Clinical Cognition Correlative Study Cytosine DNA DNA Methylation DNA Modification Process DNA analysis Data Databases Elderly Enhancers Enterobacteria phage P1 Cre recombinase Entropy Enzymes Epigenetic Process Female Future Gene Expression Gene Expression Regulation Genome Genomic Segment Genomics Goals Hippocampus Human Impaired cognition Intervention Intervention Studies Knowledge Longevity Mass Spectrum Analysis Messenger RNA Methylation Microglia Mitotic Modeling Modification Morbidity - disease rate Mus Nerve Degeneration Neurobiology Neurodegenerative Disorders Neurons Nucleic Acid Regulatory Sequences Nucleic Acids Oklahoma Parabiosis Pathway interactions Pattern Play Population Predisposition Prevention Process Proteins Proteomics RNA Rationalization Regulation Rejuvenation Research Role Sex Differences Shock Site Site-Directed Mutagenesis Specificity Stimulus Tamoxifen Testing Tissues Transgenic Organisms Visualization age related age related neurodegeneration aged aging brain base bisulfite sequencing candidate identification cell type conflict resolution design epigenome epigenome editing epigenomics experience genome-wide genomic locus human old age (65+)improved inducible Cre insight male methylation pattern middle age mortality mouse model neurogenesis novel prevent programs protein expression response sex tool transcription factor transcriptome transcriptomics whole genome

项目摘要

Abstract Epigenetic processes in the central nervous system may play a mechanistic role in susceptibility to and progression of cognitive decline and age-related neurodegenerative diseases, such as Alzheimer's. DNA modifications, principally cytosine base methylation and hydroxymethylation (mC and hmC respectively), are fundamental regulators of DNA accessibility and gene regulation/expression with differential effects on gene expression depending on the modification (mC/hmC), context CG/non-CG (also known as CH), and genomic location. A barrier to progress in understanding the role of epigenetic mechanisms in brain aging and DNA modifications in particular, has been the lack of quantitatively accurate, genome-wide data in specific cell types. Without the knowledge of the specific genomic locations of altered modifications with aging it is impossible to design well-rationalized, mechanistic studies that unravel the functional effects of epigenetic reconfiguration. Therefore, the critical next step for the field is to generate this genome-wide data of mC and hmC in CG and CH contexts in specific cell types from both sexes across the lifespan. To address this critical issue we have developed cell-type specific, tamoxifen-inducible Cre, transgenic NuTRAP models to allow isolation of nucleic acids (DNA & RNA) from microglia, astrocytes, and neurons. In Aim 1, cell type-specific hippocampal changes in mC/hmC with aging will be examined by whole genome oxidative bisulfite sequencing (WGoxBS) in microglia, astrocytes, and neurons. Paired epigenomic and transcriptomic data from the same animals will be used to: 1) assess aging with `epigenetic clocks' in a cell-type specific fashion, 2) determine the role of altered modification patterns in age-related changes in gene expression, 3) determine enrichment of differential modifications in regulatory regions of the genome, and 4) identify genomic loci for epigenome editing. In prior studies we have determined that age-related DNA modification changes can be prevented by caloric restriction. In Aim 2 we will test whether heterochronic parabiosis can reverse age-related changes once extant in the same Cre-inducible, NuTRAP models. Using a unique database of all publicly available, annotated human methylation data we will validate aspects of our findings in humans. In Aim 3 we will examine the targeting mechanisms that direct changes in mC/hmC to specific genomic regions. These studies will allow the determination of critical genomic regions with altered DNA modification patterns that can be manipulated in future interventional studies. The ultimate goal of the research is to develop clinical interventions that target the epigenome to maintain brain function with aging and prevent age-related neurodegeneration.

摘要